Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (odpre novo okno)

Cid J, Ortín X, Elies E, Díaz E.

Vir‎: Transfus Apher Sci 2003;28(1):101-2.

Indeksirano‎: PubMed 12620275

DOI‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 (odpre novo okno)

Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange. (odpre novo okno)

Dabak V, Kuriakose P, Raman S.

Vir‎: J Clin Apher 2007;22(6):330-2.

Indeksirano‎: PubMed 18080270

DOI‎: 10.1002/jca.20150

https://www.ncbi.nlm.nih.gov/pubmed/18080270 (odpre novo okno)

Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia. (odpre novo okno)

Jordan SD, Alexander E.

Vir‎: J Pharm Pract 2013;26(3):257-60.

Indeksirano‎: PubMed 22869910

DOI‎: 10.1177/0897190012451928

https://www.ncbi.nlm.nih.gov/pubmed/22869910 (odpre novo okno)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (odpre novo okno)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Vir‎: Leuk Res Rep. 2022 25;18:100355.

Indeksirano‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (odpre novo okno)

The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. (odpre novo okno)

Waddington DP, McAuley FT, Hanley JP, Summerfield GP.

Vir‎: Br J Haematol 2002;119(1):286-8.

Indeksirano‎: PubMed 12358947

https://www.ncbi.nlm.nih.gov/pubmed/12358947 (odpre novo okno)

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness. (odpre novo okno)

Walia SS, Walia MS, Walia HS.

Vir‎: Asian J Transfus Sci 2011;5(2):180-1.

Indeksirano‎: PubMed 21897605

DOI‎: 10.4103/0973-6247.83255

https://www.ncbi.nlm.nih.gov/pubmed/21897605 (odpre novo okno)